David Creen has over 20 years of experience in various roles within the healthcare industry. David most recently worked as the Vice President of Enterprise Sales at GeneType, overseeing sales operations. Prior to that, they served as a Marketing Consultant at GreenFirstPackaging. From 2022 to 2023, they were the Director of Marketing & Product Planning at Gerresheimer. Earlier in their career, David held a Vice President role at Bright Technologies, where they focused on IT sales and customer engagement. David also served as the Executive Vice President of Sales at Gatekeeper Innovation Inc., working on a patented locking cap for pharmaceutical vials. Prior to that, they were the Vice President of Business Development & Sales at Perspective Partners, specializing in fintech solutions. David also worked at Benefitfocus as a Director, managing enterprise accounts and leading a sales team. David started their career at Thomson Reuters as a Director of Client Services, providing healthcare information services. David began their career at Pfizer, Inc. as a Director of Employers - Market Strategy Group, overseeing the employer book of business. David brings a wealth of experience in sales, marketing, and business development within the healthcare industry.
David Creen has a Certificate in Marketing from Harvard T.H. Chan School of Public Health and a B.S. in Biology and English from Saint John's University.
Org chart
Teams
Offices
This person is not in any offices
GeneType
Genetype - Unlocking personalised preventative health Genetic Technologies (ASX: GTG, NASDAQ Global Market: GENE) is a leader in the development and commercialisation of genetic risk assessment technology. Significant progress has been made in understanding the role of hereditary risk in chronic disease, however, many chronic conditions cannot be predicted by this risk alone. We’re transforming the conversation. Transitioning from a one-size-fits-all model to personalised, predictive health assessment – where each person has the information, they need to manage their health according to their own risk. Backed by over 20 years of experience, our doctors, scientist and technicians are translating genetic information into multi-tests that uniquely combine genetic and clinical risk models to predict risk of chronic diseases before onset. We’re empowering physicians to improve health outcomes for people around the world. Tracking disease to its source. Enabling a new era of personalised medicine.
